Fibroblasts from chronic diseases

Our Fibrosis Fibroblasts provide a reliable and disease-specific model to study fibrotic processes and explore therapeutic interventions targeting fibrosis. Derived from fibrotic tissue, these fibroblasts retain the characteristics and molecular markers associated with fibrosis, including heightened extracellular matrix (ECM) production and altered signaling pathways that drive excessive tissue remodeling and scar formation. By using fibrosis-specific fibroblasts, researchers can obtain a more accurate representation of disease conditions compared to standard fibroblasts.
Each batch of our Fibrosis Fibroblasts undergoes strict quality control to ensure viability, functionality, and consistency, making them ideal for high-throughput screening, drug testing, and mechanistic studies. Our production process allows us to deliver fibroblasts with batch-to-batch reliability, suitable for long-term studies and multi-site research collaborations.